Emory University, U.S.
Studies from the United States, Belgium and Italy describe new findings in surgery research
Published in Pharma Law Weekly, September 26th, 2006
Study 1: Coronary artery bypass is superior to drug-eluting stents in treating multivessel coronary artery disease.
According to a recent report from the United States, "Percutaneous intervention for the treatment of multivessel coronary artery disease continues to displace coronary artery bypass graft surgery. But controlled trials of percutaneous intervention versus coronary bypass, in meta-analysis, have shown a significant survival advantage for coronary bypass."
R.A. Guyton at Emory University wrote, "Studies of bare metal stents have not...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
Source: Pharma Law Weekly (2006-09-26)
More Articles from Pharma Law Weekly
- AGA Medical
AGA Medical files suit in Germany alleging patent infringement - Bradley Pharmaceuticals
Bradley Pharmaceuticals announces initiatives to enhance shareholder value - Decision Resources
New drugs will capture share but generic erosion of Fosamax will stymie market - Diomed Holdings
Diomed wins motion on validity and enforceability of EVLT patent, trial on infringement expected - Economic and Social Research Council
Increase in drug development for killer diseases hampered by poverty in developing countries - EntreMed
Method and formulation patent issued for 2ME2 for cancer therapy - More from this issue of Pharma Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
